DEERFIELD, Ill.--(BUSINESS WIRE)--TerSera Therapeutics LLC announced today the presentation of new real-world analyses on the treatment patterns of goserelin in women with breast cancer. The data were ...

Goserelin is a type of hormone therapy. It is also known as Zoladex. You pronounce goserelin as gos-er-e-lin. This page is about goserelin for breast cancer in women who haven’t gone through menopause ...

WASHINGTON, May 30 (UPI) --The drug goserelin, sold by AstraZeneca under the brand name Zoladex, may help protect the ovaries of women with breast cancer. "It's not a panacea, but based on these data, ...

February 25, 2009 — In premenopausal women with early breast cancer, adjuvant therapy with the luteinizing hormone-releasing hormone agonist goserelin (Zoladex, AstraZeneca) decreases the long-term ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A drug that reduces the amount of estrogen in the body can help prevent ...

Final results of a clinical trial show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant ...

However, the use of the hormone-suppressing drug goserelin (Zoladex, AstraZeneca) during chemotherapy for breast cancer minimized both risks, according to results from a phase 3 study presented here ...

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, ...

Goserelin, a lutenizing hormone-releasing hormone agonist, reduces the long-term risk of disease recurrence and deaths in premenopausal women with early breast cancer who did not take tamoxifen, ...